A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma

Annals of Thoracic Surgery

Volumn 75, Issue 3, 2003, Pages 952-959

  Friedberg, Joseph S ^a   Mick, Rosemarie ^b   Stevenson, James ^b   Metz, James ^b   Zhu, Timothy ^b   Buyske, Jo ^b   Sterman, Daniel H ^b   Pass, Harvey I ^b   Glatstein, Eli ^b   Hahn, Stephen M ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TEMOPORFIN;

ACIDOSIS; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TOXICITY; BURN; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; EDEMA; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEMATOTHORAX; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPOCALCEMIA; HYPOTENSION; INTRAOPERATIVE PERIOD; ISCHEMIA; LUNG RESECTION; MALE; MALIGNANT HYPERTHERMIA; MAXIMUM TOLERATED DOSE; MESOTHELIOMA; NEUROLOGIC DISEASE; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; SENSOR; SIDE EFFECT; SKIN SENSITIVITY; SURGICAL WOUND; THORAX; THORAX TUMOR; THROMBOCYTOPENIA; TREATMENT OUTCOME; UREMIA;

AGED; CAPILLARY LEAK SYNDROME; CAUSE OF DEATH; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; INTRAOPERATIVE PERIOD; MALE; MAXIMUM TOLERATED DOSE; MESOPORPHYRINS; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS;

EID: 0037337614     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04474-0     Document Type: Article

References (18)

1. Antman KH, Pass HI, Schiff PB. Benign and malignant mesothelioma (Chap). Cancer, Principles and practice of oncology, 5th ed, DeVita VT, Hellman S, Rosenberg SA (Eds). Philadelphia: Lippincott-Raven, 1997:1853-78.
2. Ho L, Sugarbaker DJ, Skarin AT. Malignant pleural mesothelioma. Cancer Treat Res 2001;105:327-73.
3. Sugarbaker DJ, Norberto JJ, Swanson SJ. Extrapleural pneumonectomy in the setting of multimodality therapy for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 1997;9:373-82.
4. Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest 1999; 116:504-20.
5. Baas P, Murrer L, Zoetmulder FA, et al. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer 1997;76:819-26.
6. Pass HI, Tochner Z, DeLaney T, et al. Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg 1990;50:687-8.
7. Pass HI, Temeck BK, Kranda K, et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy, and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997;4:628-33.
8. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy [Review]. J Natl Cancer Inst 1998;90:889-905.
9. Berenbaum MC, Akande SL, Bonnett R, et al. Mesotetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer 1986;54:717-25.
10. Young SW, Woodburn KW, Wright M, et al. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem Photobiol 1996;63:892-7.
11. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 1998; 150:S146-56.
12. Ma L, Moan J, Berg K. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer 1994;57: 883-8.
13. van Geel IP, Oppelaar H, Oussoren YG, van der Valk MA, Stewart FA. Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin. Int J Cancer 1995;60:388-94.
14. American Joint Committee on Cancer. Cancer staging manual, 5th ed. 1997.
15. Vulcan TG, Zhu TC, Rodriguez CE, et al. Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy. Lasers Surg Med 2000;26:292-301.
16. Takita H, Dougherty TJ. Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 1995;11:368-71.
17. Ris HB, Altermatt HJ, Inderbitzi R, et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 1991;64:1116-20.
18. Kim PK, Deutschman CS. Inflammatory responses and mediators. Surg Clin North Am 2000;80:885-94.